BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2002
View Archived Issues
CPI-0004Na more effective than doxorubicin against lung metastases
Read More
Combinations containing TT-232 and cytostatics examined in murine models
Read More
Clinical benefits reported for local treatment with rHuGM-CSF in skin metastases
Read More
SPD-756: metabolism and pharmacokinetics of a new NRTI
Read More
New class of P2Y12 antagonists designed at Inspire as antithrombotics
Read More
Newly discovered H3 antagonist described in further detail by Abbott
Read More
Central nAChR agonists show cognition-enhancing and analgesic effects
Read More
Selective CCK2 antagonist undergoes clinical evaluation at JB for pancreatic cancer
Read More
Topical therapeutic AIDS vaccine demonstrates antiviral efficacy in monkeys
Read More
Santarus and TAP sign license agreement related to GI diseases
Read More
MediciNova acquires worldwide rights to novel cancer treatment
Read More
Plans discussed for Exherin phase I clinical trials
Read More
Phase I trial initiated with visilizumab in patients with ulcerative colitis
Read More
Synaptic licenses alpha2-adrenergic compounds to P&G
Read More
AltaRex receives positive opinion for OvaRex as orphan drug
Read More
French researchers identify GHB receptor modulators for use in sleep disorders
Read More
BMS claims serine protease inhibitors with anticoagulant activity
Read More
Novel anti-H. pylori agents claimed in Shionogi patent
Read More
Researchers at Bayer present Maxi-K channel openers and their use in ischemic disorders
Read More
British Biotech presents novel antibacterial/antiprotozoal agents
Read More
Novartis group identifies new adenosine A2B/A3 antagonists
Read More
Merck KGaA reports MTP inhibitors and their use in lipoprotein disorders
Read More
Rosuvastatin reported to be effective and suitable for different patient populations
Read More
BioCryst streamlines operations
Read More